- Investing Ideas
- Australian Pharmaceuticals & Biotech Nano Cap Stocks
Australian Pharmaceuticals & Biotech Nano Cap Stocks
Results
6
Stocks with a market cap under US$50M.
6 companies
Little Green Pharma
Market Cap: AU$58.0m
Produces and sells cannabis-based medicinal products across Australia and Europe.
LGP
AU$0.07
7D
-5.4%
1Y
-46.2%
Medical Developments International
Market Cap: AU$56.3m
Provides emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.54
7D
9.2%
1Y
-15.7%
Botanix Pharmaceuticals
Market Cap: AU$54.7m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.021
7D
5.0%
1Y
-86.9%
Radiopharm Theranostics
Market Cap: AU$47.7m
A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.
RAD
AU$0.011
7D
-12.5%
1Y
-61.1%
Trajan Group Holdings
Market Cap: AU$27.5m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.19
7D
2.7%
1Y
-79.6%
Vitura Health
Market Cap: AU$18.6m
Engages in the sale and distribution of medicinal cannabis products in Australia.
VIT
AU$0.031
7D
24.0%
1Y
-54.4%